Live Breaking News & Updates on Rocket pharmaceuticals

Stay informed with the latest breaking news from Rocket pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rocket pharmaceuticals and stay connected to the pulse of your community

Biotech stocks are ready to break out. They just need one more thing

Biotech stocks tend to outperform in the months leading up to an interest rate cut. But other factors are driving performance too.

Pfizer , Drug-administration , Bristol-myers-squibb , Group-fedwatch , Morgan-stanley , Rhythm-pharmaceuticals , Phathom-pharmaceuticals , Rocket-pharmaceuticals , Federal-reserve , Fed-funds , Wall-street

Rocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $39.00 price target on the biotechnology company’s stock. RCKT has been the topic of several other reports. UBS Group cut their price objective […]

China , Kinnari-patel , Gotham-makker , Jpmorgan-chase-co , Steward-partners-investment-advisory , Analyst-recommendations-for-rocket-pharmaceuticals , Wells-fargo-company , Life-insurance-co , China-universal-asset-management-co , Rocket-pharmaceuticals-inc , Needham-company , Advisor-group-holdings-inc

China Universal Asset Management Co. Ltd. Raises Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

China Universal Asset Management Co. Ltd. boosted its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,424 shares of the biotechnology company’s stock after buying an […]

China , Texas , United-states , John-militello , Kinnari-patel , Asset-management-americas-corp , Rocket-pharmaceuticals-price-performance , Securities-exchange-commission , Jpmorgan-chase-co , Allspring-global-investments-holdings , Exchange-commission , China-universal-asset-management-co

China Universal Asset Management Co. Ltd. Buys 8,356 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

China Universal Asset Management Co. Ltd. lifted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,424 shares of the biotechnology company’s stock after buying an additional 8,356 shares during the […]

China , Gaurav-shah , Gotham-makker , Rocket-pharmaceuticals-price-performance , Annandale-capital , Goldman-sachs-group , Nasdaq , Jpmorgan-chase-co , China-universal-asset-management-co , Wells-fargo-company , Steward-partners-investment-advisory , Rocket-pharmaceuticals-company-profile

Form 20-F Achilles Therapeutics For: Dec 31

Form 20-F Achilles Therapeutics For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel , Russia , Chiron , Zabaykal-skiy-kray , Odense , Syddanmark , Denmark , Liechtenstein , Canada , Norway , Delaware , United-states

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Gotham-makker , Gaurav-shah , Jpmorgan-chase-co , Rocket-pharmaceuticals-stock-performance , Rocket-pharmaceuticals-company-profile , Cantor-fitzgerald , Nasdaq , Rocket-pharmaceuticals , Institutional-investors-weigh-in-on-rocket-pharmaceuticals , News-ratings-for-rocket-pharmaceuticals-daily , Goldman-sachs-group , Rocket-pharmaceuticals-inc

Global Cell and Gene Therapy Markets Report 2024-2028

Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The

United-states , France , Canada , Mexico , Dublin , Ireland , Germany , Australia , America , Pfizer , Vericel-corp

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Brokerages

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China , Gaurav-shah , Martin-wilson , Needham-company , Rocket-pharmaceuticals , Wells-fargo-company , Steward-partners-investment-advisory , Jpmorgan-chase-co , Insider-activity-at-rocket-pharmaceuticals , News-ratings-for-rocket-pharmaceuticals-daily , Rocket-pharmaceuticals-trading-down , China-universal-asset-management-co

Rocket Pharmaceuticals (RCKT) Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Rocket Pharmaceuticals (RCKT) Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kinnari-patel , Drug-administration , European-medicines-agency , Rocket-pharmaceuticals-inc , Nasdaq , Rocket-pharmaceuticals , Marketing-authorization-application , Fanconi-anemia , Chief-operating-officer , Biologics-license-application ,

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Medioambientalesy-tecnol , Kevin-giordano , Investigaciones-energ , Kinnari-patel , Enfermedades-raras , Youtube , Linkedin , European-medicines-agency , Nasdaq , Rocket-pharmaceuticals-inc , Drug-administration